Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcatheter Tricuspid Valve Replacement Reduces Heart Failure Hospitalization: Insights From the Canadian Evoque Registry.

The Canadian journal of cardiology·2026
Same author

Tricuspid Transcatheter-Edge-to-Edge-Repair and Transcatheter Tricuspid Valve Replacement for Tricuspid Regurgitation: Patient Profiles and Outcomes.

CJC open·2026
Same author

Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.

Circulation. Cardiovascular interventions·2026
Same author

Automated Referral Prompts Reveal Lack of Equitable Access to Care in Patients With Aortic Stenosis.

Structural heart : the journal of the Heart Team·2026
Same author

Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry.

JACC. Cardiovascular interventions·2026
Same author

Fibrotic Tissue Ingrowth of Transcatheter Heart Valve Frames.

JACC. Cardiovascular interventions·2026

Related Experiment Video

Updated: Jul 2, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Transcatheter aortic valve replacement.

Anson Cheung1, Ron Ree

  • 1Division of Cardiothoracic Surgery, University of British Columbia, 1081 Burrard Street, Vancouver, BC V6Z 1X6, Canada. acheung@providencehealth.bc.ca

Anesthesiology Clinics
|September 4, 2008
PubMed
Summary
This summary is machine-generated.

Aortic stenosis is a common heart valve problem. For high-risk patients, endovascular transcatheter aortic valve replacement offers a promising alternative to traditional surgery.

Related Experiment Videos

Last Updated: Jul 2, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Aortic stenosis is a prevalent valvular heart disease in adults.
  • Conventional aortic valve replacement (AVR) via sternotomy and cardiopulmonary bypass is standard for symptomatic severe aortic stenosis.
  • High-risk patients, including the elderly and those with comorbidities, face significant operative risks with conventional AVR, with reported mortality rates up to 25%.

Purpose of the Study:

  • To explore novel treatment options for patients with symptomatic severe aortic stenosis who are poor candidates for conventional AVR.
  • To evaluate the potential of endovascular transcatheter aortic valve replacement (TAVR) as a less invasive alternative.

Main Methods:

  • Review of current literature on aortic stenosis treatment strategies.
  • Analysis of outcomes for high-risk surgical patients.
  • Examination of emerging endovascular techniques, specifically TAVR.

Main Results:

  • Conventional AVR carries substantial risk for elderly patients with comorbidities.
  • Many patients are deemed inoperable for traditional sternotomy-based AVR.
  • Transcatheter aortic valve replacement is emerging as a viable, lower-risk option for these challenging patient groups.

Conclusions:

  • Transcatheter aortic valve replacement represents a significant advancement in managing severe aortic stenosis.
  • This endovascular approach offers a potentially life-saving alternative for high-risk and nonsurgical patients.
  • Further research and adoption of TAVR can improve outcomes for a vulnerable patient population.